AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 211 filers reported holding AMICUS THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $500,992 | +298.6% | 41,200 | +312.0% | 0.00% | – |
| Q2 2023 | $125,700 | +111138.9% | 10,000 | -3.3% | 0.00% | – |
| Q1 2023 | $113 | -100.0% | 10,337 | -59.8% | 0.00% | – |
| Q3 2022 | $264,000 | -59.6% | 25,700 | -60.9% | 0.00% | – |
| Q2 2021 | $654,000 | -51.8% | 65,675 | -54.6% | 0.00% | -100.0% |
| Q1 2021 | $1,358,000 | +35.9% | 144,609 | +232.2% | 0.00% | +50.0% |
| Q4 2020 | $999,000 | +108.6% | 43,529 | +28.0% | 0.00% | +100.0% |
| Q3 2020 | $479,000 | -52.6% | 34,007 | -47.7% | 0.00% | -66.7% |
| Q2 2020 | $1,011,000 | +30.6% | 65,013 | -18.5% | 0.00% | +50.0% |
| Q1 2020 | $774,000 | -21.3% | 79,746 | -22.8% | 0.00% | -33.3% |
| Q4 2019 | $984,000 | +116.3% | 103,240 | +83.0% | 0.00% | +200.0% |
| Q3 2019 | $455,000 | -61.5% | 56,400 | -40.5% | 0.00% | -75.0% |
| Q2 2019 | $1,181,000 | +36.1% | 94,737 | +48.3% | 0.00% | +33.3% |
| Q1 2019 | $868,000 | +26.9% | 63,888 | -13.7% | 0.00% | 0.0% |
| Q4 2018 | $684,000 | -68.3% | 74,047 | -58.6% | 0.00% | -40.0% |
| Q3 2018 | $2,160,000 | -44.6% | 178,681 | -31.1% | 0.01% | -44.4% |
| Q2 2018 | $3,899,000 | 0.0% | 259,275 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $3,899,000 | +61.2% | 259,275 | +54.3% | 0.01% | +12.5% |
| Q4 2017 | $2,418,000 | -4.6% | 168,004 | -0.0% | 0.01% | -11.1% |
| Q3 2017 | $2,534,000 | +116.0% | 168,063 | +42.3% | 0.01% | +80.0% |
| Q2 2017 | $1,173,000 | +113.3% | 118,100 | +54.8% | 0.01% | +66.7% |
| Q1 2017 | $550,000 | -3.5% | 76,300 | -33.4% | 0.00% | 0.0% |
| Q4 2016 | $570,000 | -21.6% | 114,581 | +11.5% | 0.00% | -25.0% |
| Q3 2016 | $727,000 | +28.7% | 102,800 | -1.4% | 0.00% | +33.3% |
| Q2 2016 | $565,000 | – | 104,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |